Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Value of preemptive CYP2C19 genotyping in allogeneic stem cell transplant patients considered for pentamidine administration
Lawrence B. Afrin, Jessica B. Afrin
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Value of preemptive CYP2C19 genotyping in allogeneic stem cell transplant patients considered for pentamidine administration'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Transplant Patients
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Pentamidine
100%
CYP2C19
100%
High Dose
10%
Pneumocystis Jirovecii
10%
Hospital Charges
10%
Active Infection
10%
Toxicity Management
10%
Human Metabolism
10%
Preemptive Genotyping
10%
Polynesian
10%
Medicine and Dentistry
Stem Cell Transplant
100%
CYP2C19
100%
Pentamidine
100%
Allogeneic Stem Cell Transplantation
40%
Health Care Cost
10%
Infection
10%
Low Drug Dose
10%
Drug Megadose
10%
Pneumocystis Jirovecii
10%
Human Metabolism
10%
Cytochrome P450 2C19 Inhibitor
10%
Immunology and Microbiology
Stem Cell Transplant
100%
Pentamidine
100%
Allogeneic Stem Cell Transplantation
40%
Low Drug Dose
10%
Drug Megadose
10%
Pneumocystis Jiroveci
10%